Expanding the mutational spectrum ofGCKin Turkish pediatric population
Vehap Topcu,
Gonul Buyukyilmaz,
Keziban Toksoy Adiguzel
et al.
Abstract:Glucokinase (GCK) is a central enzyme that keeps integrity of glucose metabolism. Heterozygous loss-of-function variants in GCK cause persistent, mildly elevated plasma glucose beginning at birth. Recently, clinical phenotype created by deleterious variants in GCK is called GCK-MODY, although currently registered as MODY, type 2 (maturity-onset diabetes of the young type 2, MODY2, MIM # 125851) in OMIM. Severity of clinical phenotype is consistent among patients due to the compensation from the unaffected alle… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.